Back
Speaker illustration

Doctor Daniel Engelbertsen

(Sweden)

Articles

Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation

Date: 2 April 2024

Journal: Cardiovascular Research

Access
Like
Thumbnail

S100A9 blockade ameliorates cardiac dysfunction and reduces myocardial immune infiltration in experimental autoimmune myocarditis

Date: 10 June 2022

Journal: Cardiovascular Research

Access
Like
Thumbnail

IL-1R and MyD88 signalling in CD4<sup>+</sup> T cells promote Th17 immunity and atherosclerosis

Date: 28 September 2017

Journal: Cardiovascular Research

Access
Like
Thumbnail

Induction of T helper 2 responses against human apolipoprotein B100 does not affect atherosclerosis in ApoE<sup>−/−</sup> mice

Date: 27 May 2014

Journal: Cardiovascular Research

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources